GlaxoSmithKline plc (GSK)

Last Price:  

Company Description

GlaxoSmithKline is one of the world's leading research based pharmaceutical and healthcare companies and is committed to improving the quality of human life by enabling people to do more, feel better and live longer. They also have leadership in four major therapeutic areas: anti-infectives, central nervous system (CNS), respiratory and gastro-intestinal/metabolic.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $43.79B
Net Income (Most Recent Fiscal Year) $7.38B
PE Ratio (Current Year Earnings Estimate) 13.88
PE Ratio (Trailing 12 Months) 13.13
PEG Ratio (Long Term Growth Estimate) 2.04
Price to Sales Ratio (Trailing 12 Months) 2.36
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 3.47
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) 10.03
Pre-Tax Margin (Trailing 12 Months) 16.88%
Net Margin (Trailing 12 Months) 13.40%
Return on Equity (Trailing 12 Months) 26.21%
Return on Assets (Trailing 12 Months) 6.97%
Current Ratio (Most Recent Fiscal Quarter) 0.82
Quick Ratio (Most Recent Fiscal Quarter) 0.53
Debt to Common Equity (Most Recent Fiscal Quarter) 0.95
Inventory Turnover (Trailing 12 Months) 1.78
Book Value per Share (Most Recent Fiscal Quarter) $9.92
Earnings per Share (Most Recent Fiscal Quarter) $0.79
Earnings per Share (Most Recent Fiscal Year) $2.98
Diluted Earnings per Share (Trailing 12 Months) $2.37
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers - General
Common Shares Outstanding 2.69B
Free Float 2.42B
Market Capitalization $104.61B
Average Volume (Last 20 Days) 3.11M
Beta (Past 60 Months) 0.70
Percentage Held By Insiders (Latest Annual Proxy Report) 10.00%
Percentage Held By Institutions (Latest 13F Reports) 12.25%
Annual Dividend (Based on Last Quarter) $2.09
Dividend Yield (Based on Last Quarter) 5.38%